Notice2022-22028
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 11, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 195 (Tuesday, October 11, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 195 (Tuesday, October 11, 2022)]
[Notices]
[Pages 61326-61327]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-22028]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22GG]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Pilot Plan for the Interim Local Health
Department Strategy for Response, Control, and Prevention of Healthcare
Associated Infections (HAI) and Antibiotic Resistance (AR)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection
[[Page 61327]]
Submitted for Public Comment and Recommendations'' notice on June 17th,
2022 to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Pilot Plan for the Interim Local Health Department Strategy for
Response, Control, and Prevention of Healthcare Associated Infections
(HAI) and Antibiotic Resistance (AR)--New--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Through piloting the Interim Local Strategy, CDC's Division of
Healthcare Quality Promotion (DHQP) aims to understand Local Health
Departments' (LHDs) experience implementing the strategy and collect
their feedback for refinement. A secondary goal of this study is to
create a network of LHDs working in Healthcare Associated Infections
(HAI) and Antibiotic Resistance (AR) activities to learn from one
another and share best practices. Data collected during the pilot will
be used to assess the extent to which the strategy materials and
resources help LHDs to: (1) grow and expand their HAI/AR partner
networks and collaboration; (2) build operational capacity to conduct
and promote sustainable HAI/AR infection prevention and control
practices; and (3) expand HAI/AR infection prevention, outbreak
response, and stewardship activities. Furthermore, data will inform any
necessary refinements of the materials and resources.
CDC will conduct data collection through interviews and electronic
surveys, to capture feedback on the strategy's usability and
effectiveness, as well as on each individual material and resource. CDC
will use a mixed methods approach with both deductive and inductive
analysis of qualitative data collected through surveys and structured
interviews, and aggregate quantitative survey data.
CDC requests OMB approval for an estimated 360 annualized burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Voluntary LHD Participants/NACCHO Coag LHD HAI/AR Strategy 60 1 4
LHD participants. Pilot Feedback Form.
Voluntary LHD Participants............ LHD HAI/AR Strategy 30 1 2
Pilot Interview Guide.
NACCHO CoAg LHD Participants.......... LHD HAI/AR Strategy 30 1 2
Pilot Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-22028 Filed 10-7-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on October 11, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.